Items where Author is "Tahmasebi, F"

Breedon, JR, Marshall, CR, Giovannoni, G, van Heel, DA, Akhtar, S, Anwar, M, Arciero, E, Asgar, O, Ashraf, S, Breen, G, Chung, R, Curtis, CJ, Chaudhary, S, Chowdhury, M, Colligan, G, Deloukas, P, Durham, C, Durrani, F, Eto, F, Finer, S et al (2023) Polygenic risk score prediction of multiple sclerosis in individuals of South Asian ancestry. Brain Communications, 5 (2).

Pathak, GA, Karjalainen, J, Stevens, C, Neale, BM, Daly, M, Ganna, A, Andrews, SJ, Kanai, M, Cordioli, M, Polimanti, R, Harerimana, N, Pirinen, M, Liao, RG, Chwialkowska, K, Trankiem, A, Balaconis, MK, Nguyen, H, Solomonson, M, Veerapen, K, Wolford, B et al (2022) A first update on mapping the human genetic architecture of COVID-19. Nature, 608 (7921). E1-E10. ISSN 0028-0836

Hodgson, S, Huang, QQ, Sallah, N, Griffiths, CJ, Newman, WG, Trembath, RC, Wright, J, Lumbers, RT, Kuchenbaecker, K, van Heel, DA, Mathur, R, Martin, HC, Finer, S and Tahmasebi, F (2022) Integrating polygenic risk scores in the prediction of type 2 diabetes risk and subtypes in British Pakistanis and Bangladeshis: A population-based cohort study. PLOS Medicine, 19 (5).

Feng, S, Phillips, DJ, White, T, Sayal, H, Aley, PK, Bibi, S, Dold, C, Fuskova, M, Gilbert, SC, Hirsch, I, Humphries, HE, Jepson, B, Kelly, EJ, Plested, E, Shoemaker, K, Thomas, KM, Vekemans, J, Villafana, TL, Lambe, T, Pollard, AJ et al (2021) Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nature Medicine, 27 (11). pp. 2032-2040. ISSN 1078-8956

Flaxman, A, Marchevsky, NG, Jenkin, D, Aboagye, J, Aley, PK, Angus, B, Belij-Rammerstorfer, S, Bibi, S, Bittaye, M, Cappuccini, F, Cicconi, P, Clutterbuck, EA, Davies, S, Dejnirattisai, W, Dold, C, Ewer, KJ, Folegatti, PM, Fowler, J, Hill, AVS, Kerridge, S et al (2021) Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). Lancet, 398 (10304). pp. 981-990. ISSN 0140-6736

Frater, J, Ewer, KJ, Ogbe, A, Pace, M, Adele, S, Adland, E, Alagaratnam, J, Aley, PK, Ali, M, Ansari, MA, Bara, A, Bittaye, M, Broadhead, S, Brown, A, Brown, H, Cappuccini, F, Cooney, E, Dejnirattisai, W, Dold, C, Fairhead, C et al (2021) Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial. The lancet. HIV, 8 (8). e474-e485. ISSN 2405-4704

Voysey, M, Costa Clemens, SA, Madhi, SA, Weckx, LY, Folegatti, PM, Aley, PK, Angus, B, Baillie, VL, Barnabas, SL, Bhorat, QE, Bibi, S, Briner, C, Cicconi, P, Clutterbuck, EA, Collins, AM, Cutland, CL, Darton, TC, Dheda, K, Dold, C, Duncan, CJA et al (2021) Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. The Lancet, 397 (10277). pp. 881-891. ISSN 0140-6736